Related StoriesAir Liquide Healthcare launches a website dedicated to sleep do we rest apneaWhy?

Actavis signs deal with Cephalon to stay patent litigation related to Nuvigil tablets Actavis plc today announced that it has entered into an contract with Cephalon, Inc. Related StoriesAir Liquide Healthcare launches a website dedicated to sleep do we rest apneaWhy?S. Sales of approximately $437 million, regarding to IMS Health data.In addition, the trial assessed the secondary end result measures of medical response at Day 14 along with at Time 28. The single-dosage of DALVANCE provided very similar treatment efficacy to both dose program in these secondary endpoints. 94.4 percent of patients in the single-dose DALVANCE arm and 94.0 percent of individuals in the two-dose DALVANCE arm achieved medical success at Day 14 . At Day 28, 84.5 percent of patients treated with a single-dose of DALVANCE achieved clinical success compared to 85.1 percent of these treated with the two-dose regimen of DALVANCE .